魯泰A(000726.SZ):擬收購山東中康國創先進印染技術研究院2%的股權
格隆匯4月6日丨魯泰A(000726.SZ)公佈,2020年4月3日,公司與山東中康國創先進印染技術研究院有限公司(“中康國創”)股東泰安民意節能設備有限公司(“泰安民意節能”)簽署了《股權轉讓協議》,公司擬收購其持有的中康國創2%的股權,對泰安民意節能的支付對價為0元。此次收購資產事項不構成關聯交易、不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
若此次交易完成,公司將在先進紡織印染技術應用方面獲得更多支撐,提高公司在紡織印染行業的技術水平、產品品質和競爭力,為紡織工業高質量發展積蓄力量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.